Colchicine use in the damaged disk syndrome (DDS). Report of 50 patients

Fifty patients with acute and chronic damaged disk syndromes responded (68% good or excellent results) to minimal colchicine usage (0.6 to 1.2 mg per day), indicating that more complicated measures may be avoided in many distressed patients who suffer from disk disease. The usefulness of colchicine is slightly better in the acute than in the chronic disk syndrome, but any disk-suffering patient deserves a therapeutic trial of this possibly valuable medicament, before progressing to more complex, invasive procedures.